Dane D. Jensen

Pain Management Institute — United States

Neuroscience · Life Sciences

24h-index2.6kcitations66works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuropeptides and Animal Physiology(20), Receptor Mechanisms and Signaling(16), Pain Mechanisms and Treatments(14), Blood Coagulation and Thrombosis Mechanisms(7), Cellular transport and secretion(5)

Publications66 total

Endosomal MrGPRX1 signaling sensitizes TRPV1 to enhance itch
2025Open Access
Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesia
Proceedings of the National Academy of Sciences·2025· 3 citedOpen Access
Nanoparticle-mediated antagonism of sustained endosomal signaling of the calcitonin receptor-like receptor provides enhanced and persistent relief of oral cancer pain
Biomaterials·2025Open Access
A Bacteroides fragilis protease activates host PAR2 to induce intestinal pain and inflammation
Cell Host & Microbe·2025· 4 citedOpen Access
Targeting prostaglandin E2 receptor 2 in Schwann cells inhibits inflammatory pain but not inflammation
Nature Communications·2025Open Access
Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice
British Journal of Pharmacology·2025· 1 citedOpen Access
PAR2 Antagonism Drug Delivery with Nanoparticles Block Nociception in Osteoarthritis Models
Journal of Pain·2025
Compartmentalized Signaling of Mas-related G-protein Coupled Receptor X1 (MrGPRX1) and Transient Receptor Potential Vanilloid (TRPV) Channels in Pain and Itch Pathways
Journal of Pain·2025
Characterization and targeting of the endosomal signaling of the gastrin releasing peptide receptor in pruritus
2025· 2 citedOpen Access
Identification of a secreted protease from Bacteroides fragilis that induces intestinal pain and inflammation by cleavage of PAR2
2025· 7 citedOpen Access
PAR2 on oral cancer cells and nociceptors contributes to oral cancer pain that can be relieved by nanoparticle-encapsulated AZ3451
Biomaterials·2024· 15 citedOpen Access
Targeting the Schwann Cell EP2/cAMP Nanodomain to Block Pain but not Inflammation
2024· 2 citedOpen Access
Nanomedicines targeting signaling of protease-activated receptor 2 in organelles provide sustained analgesia
2024· 2 cited
Light-scattering assay of mitochondrial permeability transition in intact cells
Biochimica et Biophysica Acta (BBA) - Bioenergetics·2024
Comparative Analysis of Nucleic Acid-Binding Polymers as Potential Anti-Inflammatory Nanocarriers
Pharmaceutics·2023· 12 citedOpen Access
Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance
Pharmaceuticals·2023· 7 citedOpen Access
Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief
Proceedings of the National Academy of Sciences·2023· 41 citedOpen Access
Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain
Biomaterials·2022· 42 citedOpen Access
Advances in Head and Neck Cancer Pain
Journal of Dental Research·2022· 40 citedOpen Access
Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice
Nature Communications·2022· 143 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Nigel W. Bunnett(33), Rocco Latorre(18), Brian L. Schmidt(18), Daniel P. Poole(14), Nicholas A. Veldhuis(12), Stephen Vanner(10), Nestor N. Jiménez-Vargas(9), TinaMarie Lieu(8), Pierangelo Geppetti(7), Meritxell Canals(7), Peishen Zhao(7), Jeffri S. Retamal(7), Shavonne Teng(7), Chloe J. Peach(7), Romina Nassini(6), Alan Hégron(6), Kam W. Leong(6), Michelle L. Halls(5), Divya Bhansali(5), Wendy L. Imlach(4)